Abstract
Prior studies have demonstrated that the mouse hepatitis virus (MHV) A59 strain ns2 protein is a member of the 2H phosphoesterase family and exhibits 2′,5′-phosphodiesterase (PDE) activity. During the IFN antiviral response, ns2 cleaves 2′,5′-oligoadenylate (2-5A), a key mediator of RNase L activation, thereby subverting the activation of RNase L and evading host innate immunity. However, the mechanism of 2-5A cleavage by ns2 remains unclear. Here, we present the crystal structure of the MHV ns2 PDE domain and demonstrate a PDE fold similar to that of the cellular protein, a kinase anchoring protein 7 central domain (AKAP7CD) and rotavirus VP3 carboxy-terminal domain. The structure displays a pair of strictly conserved HxT/Sx motifs and forms a deep, positively charged catalytic groove with β-sheets and an arginine-containing loop. These findings provide insight into the structural basis for 2-5A binding of MHV ns2.
Innate immunity, which is commonly triggered by dsRNA in eukaryotic cells, plays a crucial role in viral defence (Wang & Carmichael, 2004). The 2′,5′-oligoadenylate (2-5A) synthase (OAS)/RNase L system, which is one of the most effective IFN-induced antiviral pathways, utilizes several strategies to inhibit viral infections (Silverman, 2007). Viruses induce the production of type I IFN, resulting in the activation of hundreds of IFN-stimulated genes, including four or more OAS genes (Der et al., 1998; Kristiansen et al., 2011; Schindler & Darnell, 1995; Stark et al., 1998). OASs 1–3 use ATP to synthesize a series of 2-5A molecules consisting of [p3A(2′p5′A)n, n ≥ 2] upon stimulation by viral dsRNA (Hovanessian & Justesen, 2007; Kerr & Brown, 1978). These 2-5A molecules bind to the N-terminal ankyrin repeat and central protein kinase-like domains of RNase L, causing inactive RNase L monomers to form activated dimers with potent RNase activity that preferentially cleave single-stranded viral or cellular RNA after UU and UA repeats (Cole et al., 1997; Dong & Silverman, 1995; Han et al., 2014; Huang et al., 2014).
Both coronavirus and rotavirus families include pathogens that can lead to severe diseases in humans and animals (Desselberger, 2014; Zaki et al., 2012). Prior studies have reported that coronavirus mouse hepatitis virus (MHV) and group A rotavirus (RVA) encode ns2 and VP3 proteins, respectively. Ns2 and VP3 carboxy-terminal domain (CTD) belong to the 2H phosphoesterase superfamily, containing two conserved HxT/Sx motifs (where H represents histidine and x denotes a hydrophobic residue). Both ns2 and VP3 display 2′,5′-phosphodiesterase (PDE) activity, which can inhibit the activation of RNase L through degradation of its activator 2-5A, thereby antagonizing the OAS/RNase L pathway and evading host innate immunity (Zhang et al., 2013; Zhao et al., 2012). AKAP7 is a member of the AKAP family that localizes to nuclei and has a central domain (esidues 87-292, AKAP7CD) that belongs to the 2H phosphoesterase superfamily. AKAP7 exhibits 2′,5′-PDE activity that can complement an inactive MHV ns2 gene and degrade 2-5A with kinetics similar to that of MHV ns2 (Gold et al., 2008; Gusho et al., 2014). Although from different origins, these proteins display 2′,5′-PDE activity and can prevent the activation of RNase L by cleaving 2-5A.
To further elucidate the mechanism by which MHV ns2 binds and cleaves 2-5A, we resolved the crystal structure of the PDE domain of MHV-A59 ns2. The full-length ns2 protein containing residues 1–261 readily aggregates, possibly due to its cysteine-rich (six cysteines in a 62 aa segment, approximately 10 %) carboxy-terminal region. Thus, to select an ns2 fragment suitable for crystallization, we designed a series of C-terminally truncated constructs of ns2 based on a secondary structure prediction for this protein. An ns2 fragment containing residues 1–199 (ns21–199) including the PDE activity domain (residues 6–186) exhibited improved expression and solubility compared with the full-length protein (Fig. 1a, b and data not shown). To purify the ns21–199 protein, the codon-optimized sequence of truncated MHV-A59 ns21–199 was cloned into pET-42b vector (Novagen) with a 6 × His tag at the C terminus. Expression of ns21–199 protein was induced in Escherichia coli Rosetta BL21(DE3) (at an OD600 of 0.7) with 0.5 mM IPTG. After incubation for 18 h at 18 °C, the cells were collected and homogenized in PBS. After centrifugation at 10 000 g for 10 min, the supernatant was applied to Ni2+ affinity resin (Ni-NTA; GE) and further purified by gel filtration chromatography on Superdex 75 (GE Healthcare). The final protein preparation (at 10 mg ml− 1) containing 20 mM Tris/HCl (pH 7.4) and 200 mM NaCl was crystallized using the hanging-drop vapour-diffusion method at 4 °C with a reservoir solution containing 16 % (w/v) polyethylene glycol 3350, 0.1 M succinic acid (pH 7.0) and 20 mM hexamminecobalt(III) chloride. Selenomethionine (SeMet)-labelled protein was overexpressed in M9 minimal salts, and purified in the same way as the unmodified protein. The first crystal appeared 2 days post-seeding and the crystals were harvested for X-ray diffraction analysis 2 weeks later. However, the resolution was not high enough for data collection (3.6 Å), so dehydration was applied according to the protocols described by Heras & Martin (2005). The crystals were soaked in dehydration buffer containing 0.5 M succinic acid (pH 7.0) and 25 % polyethylene glycol 3350 for 1 month. Diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF) and then integrated and scaled using the HKL2000 package (Otwinowski & Minor, 1997). The structure of ns21–199 was determined by single-wavelength anomalous diffraction (SAD) phasing using SeMet-labelled ns21–199 and four SeMet sites in ns21–199 were identified. Model building and refinement were iteratively conducted using phenix and coot (Adams et al., 2002; Emsley & Cowtan, 2004). Data collection and refinement statistics for the ns21–199 crystal structure are provided in Table S1 (available in the online Supplementary Material). The ns21–199 structure was determined to within 3.05 Å. Since the residues of 1–6 and 168–199 were disordered and could not be resolved, we chose the ordered region (residues 7–167) as the final model, defined as ns27–167 (Fig. 1c–e).
To our knowledge, the crystal structure of the PDE domain of ns2 is the first coronavirus 2′,5′-PDE structure to be reported. Based on an overview of the structure of ns27–167, we found that this protein features a globular α/β-type architecture consisting of three α-helices and nine β-sheets with approximate dimensions of 48 Å × 46 Å × 16 Å (Fig. 1c, d). The structure is bilobal, with β1/2/3/5/6/7/9 and an arginine (R)-containing loop (R-loop, the loop between α3 and β7) that forms a concave surface where the electrostatic potential is positive and presumed to be the domain in which the negatively charged 2-5A binds and is cleaved (Fig. 1e) (Gold et al., 2008). In accordance with the definition of the 2H phosphoesterase family, the β3 strand harbours an HxSx (where x is a hydrophobic residue) motif, and the β7 strand harbours an HxTx motif (Fig. 2a, b). This pair of HxT/Sx motifs play a key role in 2′,5′-PDE activity and are conserved in the ns2 homologues of other group 2a betacoronaviruses, including human virus OC43 and toroviruses (Silverman & Weiss, 2014). Prior research has demonstrated that mutations at the catalytic residues H46 and H126 in conserved HxT/Sx motifs of ns2 abolish PDE activity in vitro and severely impact virus replication in vivo (Zhao et al., 2011, 2012).
MHV ns2, VP3-CTD and AKAP7CD are representative 2H phosphoesterases (Fig. 1a) (Gusho et al., 2014; Zhang et al., 2013; Zhao et al., 2012). Based on the sequence alignment, we identified a number of conserved residues in these 2H phosphoesterases (Fig. 2a). The structures of AKAP7CD (PDB ID 2VFY) and VP3-CTD (PDB ID 5AF2), which exhibit substantial structural homology, have previously been determined (Brandmann & Jinek, 2015; Ogden et al., 2015). The structural alignment of ns27–167, AKAP7CD and VP3-CTD indicated that all of these structures form similar positive electrostatic concave regions in the 2′,5′-PDE activity domain, which is putatively involved in the binding and cleavage of 2-5A (Fig. 2b, c). In addition, the two conserved HxT/Sx motifs at the H46/S48/H126/T128 residues of ns2 were located in positions similar to those of the H132/T134/H224/T226 residues of AKAP7CD and the H718/T720/H797/T799 residues of VP3-CTD (Fig. 2d). The arginine that is important for stabilizing 2-5A has previously been reported to be present in the R-loop region and is also strictly conserved in those three proteins (Fig. 2a, d) (Ogden et al., 2015). All of the aforementioned characteristics demonstrate the structural conservation of the PDE catalytic domain of these three 2H phosphoesterases, despite lacking significant sequence homology (Fig. 2a).
Both MHV ns2 and RVA VP3 are viral proteins that display 2′,5′-PDE activity, although there are subtle differences between the ns27–167 and VP3-CTD structures. The ns27–167 structure displays α-helices in the region from S19 to M35 (α1), which is similar to AKAP7CD, whereas VP3-CTD shows a loop in this region that is much shorter compared with ns27–167 (Fig. 2b). The regions from residues D79 to D83 (β4) and Y144 to P148 (β8) display two β-sheets that are similar to those of AKAP7CD, whereas the similar regions of VP3-CTD show two loops. Although some differences are seen between ns27–167 and VP3-CTD, these two proteins show greater structural similarities in their PDE catalytic domains between themselves than compared with AKAP7CD [AKAP7CD, with a root mean square deviation (RMSD) of 2.41 Å between the 149 Cα atoms. VP3-CTD, with the RMSD of 1.67 Å between the 148 Cα atoms. Analysed by PDBeFold.], having nearly identical β sheet coordinates (β1/3/6/7) (Fig. 2e). Prior studies have demonstrated that the L758 residue plays a key role in VP3-CTD activity (Ogden et al., 2015); ns27–167 has an L88 in this position, although AKAP7CD contains a Q residue in this position (Fig. 2a). Two α-helices at the position of α2/α3 in ns27–167 are also conserved in these three proteins, although ns2 and VP3 have shorter α-helices in α3 than does AKAP7CD. The sequence alignment of ns21–199, VP3-CTD and AKAP7CD illustrates that ns21–199 and VP3-CTD share greater sequence homology compared with AKAP7CD (Fig. 2a). According to these features, we can conclude that ns27–167 not only displays structural features of AKAP7CD but also of VP3-CTD, and ns27–167 shares greater sequence or structural homology with VP3-CTD compared with AKAP7CD.
It has previously been reported that AKAP7CD can bind 5′AMP (Gold et al., 2008). Ns2 and AKAP7 present similar PDE domains and conserved key residues based on sequence or structural alignment. The structure of AKAP7CD binding to 5′AMP (PDB ID 2VFK) indicates that H224 from the second HxT/Sx motif forms a hydrogen bond with the bridging ester oxygen, and two threonines (T134/T226) from the two HxT/Sx motifs form hydrogen bonds with the phosphate oxygen atoms (Fig. 3a). The R219 in the R-loop region forms a cation–π interaction with the adenine moiety of 5′AMP of AKAP7 (Gold et al., 2008). Ns27–167 showed similar residues, H46/R121/T128, in similar coordinates, with the only difference being the presence of a serine (S48) in ns2 (Fig. 3b). Both threonine and serine can present a hydroxyl group, which could potentially donate hydrogen bonds to the phosphate oxygen atoms of 5′AMP. From the published structure of VP3-CTD in complex with 2-5A (PDB ID 4YE2), it can be observed that the residues T720, H797 and T799 of the HxT/Sx motifs interact with 5′ monophosphate of the 5′ adenosine in 2-5A via hydrogen bonds (Fig. 3c, d) (Ogden et al., 2015). H718 donates hydrogen bonds to the phosphate oxygen atom and further stabilizes 2-5A. R792 in the R-loop forms a cation-interaction with the adenine base of the substrate. These residues stabilize 2-5A. ns2 displays similar HxT/Sx motifs and residues at similar coordinates, which provide the structural basis for binding 2-5A (Fig. 3d). These structural features demonstrate a similar mechanism in degrading 2-5A.
Prior studies have reported that MHV ns2 and the cellular protein AKAP7 exhibit similar 2′,5′-PDE enzymic activity in degrading 2-5A (Gusho et al., 2014). To compare the activities of these proteins and to verify the activity of the truncated ns2 used for crystallization, mammalian expression vectors pCAGGS and pCAGGS encoding ns21–199, ns21–199H126R, AKAP7CD and AKAP7CDH224R proteins with a C-terminal FLAG tag were individually transfected into 293T cells. At 48 h post-transfection, cells were collected and analysed by Western blotting. All of the proteins tested were expressed at high levels in human 293T cells (Fig. 3e). To compare the 2′,5′-PDE activity of truncated ns21–199 protein with that of the other proteins in intact cells, pCAGGS and pCAGGS plasmids encoding WT ns2, ns21–199, ns21–199H126R, AKAP7CD and AKAP7CDH224R were transfected into 293T cells. At 18 h after transfection, cells were treated with poly(rI) : poly(rC) to activate OAS. The cells were incubated for an additional 6 h before being harvested. Subsequently, 2-5A was isolated and then quantified using a fluorescence resonance energy transfer (FRET) assay as previously reported (Thakur et al., 2005). We clearly demonstrated that ns21–199 cleaved 2-5A and that the mutant ns21–199H126R protein lacked 2′,5′-PDE activity. Levels of 2′,5′-PDE activity were compared among ns21–199, full-length ns2, and AKAP7CD (Fig. 3f). The results demonstrated that full-length ns2 and the AKAP7CD displayed similar 2′,5′-PDE activity, whereas they lost catalytic activity after the key histidine was mutated. Truncated ns2 (residues 1–199) retained 2′,5′-PDE activity, although reduced compared with full-length WT ns2. It is possible that some residues in the carboxy-terminal domain of ns2 may enhance 2′,5′-PDE activity.
The structural analysis showed that the key residues in HxT/Sx motifs of ns2 protein were strictly conserved and located at similar coordinates compared with those of AKAP7CD and VP3-CTD. This structure also revealed that the conserved arginine in the R-loop region might play a key role in stabilizing the adenine moiety. These structural features suggest that these proteins bind and degrade 2-5A in a similar way. Based on the structural alignment of ns27–167, AKAP7CD and VP3-CTD, we demonstrate that ns27–167 exhibits features of both AKAP7CD and VP3-CTD, whereas ns27–167 and VP3-CTD show greater sequence and structural homology (Fig. 2a, e). Previously, it has been speculated that MHV and some other viruses acquired ancestral precursors of viral 2′,5′-PDE genes from their hosts. Homologous recombination might have occurred between the MHV genome and host RNA, thus endowing viruses with the ability to antagonize innate immunity by degrading 2-5A (Gusho et al., 2014; Luytjes et al., 1988). Here, we provide further evidence for this concept at the structural level.
The family Coronaviridae, a large family of viruses, have the largest genomes among RNA viruses. The precise mechanisms by which these viruses evade innate immunity are complicated and remain to be fully elucidated. Several emerging infectious disease outbreaks in recent years were caused by coronaviruses, including severe acute respiratory syndrome (SARS), porcine epidemic diarrhea virus and Middle East respiratory syndrome (MERS). MHV, MERS and SARS all belong to the betacoronavirus family. To our knowledge, the crystal structure of the truncated PDE domain of MHV ns2 is the first ns2 PDE domain structure of any coronavirus to be solved. By resolving and analysing the structure of ns27–167, we demonstrated the structural basis for binding with 2-5A and obtained insight into the mechanism by which MHV, and perhaps other coronaviruses, evades host innate immunity.
Acknowledgements
We thank the staff at the SSRF beam line BL17U1 for assistance with X-ray data collection. This work was partially supported by the National Natural Science Foundation of China (31372419) to L. Z. and NIH/NIAID grant AI104887 to S. R. W. and R. H. S.
Supplementary Data
Footnotes
Atomic coordinates and structure factor amplitudes for MHV-A59 ns27–167 have been deposited in the Protein Data Bank (PDB) under accession code 4Z5V.
One supplementary table is available with the online Supplementary Material.
References
- Adams P. D., Grosse-Kunstleve R. W., Hung L.-W., Ioerger T. R., McCoy A. J., Moriarty N. W., Read R. J., Sacchettini J. C., Sauter N. K., Terwilliger T. C. (2002). phenix: building new software for automated crystallographic structure determination Acta Crystallogr D Biol Crystallogr 581948–1954 10.1107/S0907444902016657. [DOI] [PubMed] [Google Scholar]
- Brandmann T., Jinek M. (2015). Crystal structure of the C-terminal 2′,5′-phosphodiesterase domain of group A rotavirus protein VP3 Proteins 83997–1002 10.1002/prot.24794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cole J. L., Carroll S. S., Blue E. S., Viscount T., Kuo L. C. (1997). Activation of RNase L by 2′,5′-oligoadenylates. Biophysical characterization J Biol Chem 27219187–19192 10.1074/jbc.272.31.19187. [DOI] [PubMed] [Google Scholar]
- Der S. D., Zhou A., Williams B. R., Silverman R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci U S A 9515623–15628 10.1073/pnas.95.26.15623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desselberger U. (2014). Rotaviruses Virus Res 19075–96 10.1016/j.virusres.2014.06.016. [DOI] [PubMed] [Google Scholar]
- Dong B., Silverman R. H. (1995). 2-5A-dependent RNase molecules dimerize during activation by 2-5A J Biol Chem 2704133–4137 10.1074/jbc.270.8.4133. [DOI] [PubMed] [Google Scholar]
- Emsley P., Cowtan K. (2004). Coot: model-building tools for molecular graphics Acta Crystallogr D Biol Crystallogr 602126–2132 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- Gold M. G., Smith F. D., Scott J. D., Barford D. (2008). AKAP18 contains a phosphoesterase domain that binds AMP J Mol Biol 3751329–1343 10.1016/j.jmb.2007.11.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gusho E., Zhang R., Jha B. K., Thornbrough J. M., Dong B., Gaughan C., Elliott R., Weiss S. R., Silverman R. H. (2014). Murine AKAP7 has a 2′,5′-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene MBio 5e01312–e01314 10.1128/mBio.01312-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Han Y., Donovan J., Rath S., Whitney G., Chitrakar A., Korennykh A. (2014). Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response Science 3431244–1248 10.1126/science.1249845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heras B., Martin J. L. (2005). Post-crystallization treatments for improving diffraction quality of protein crystals Acta Crystallogr D Biol Crystallogr 611173–1180 10.1107/S0907444905019451. [DOI] [PubMed] [Google Scholar]
- Hovanessian A. G., Justesen J. (2007). The human 2′-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation Biochimie 89779–788 10.1016/j.biochi.2007.02.003. [DOI] [PubMed] [Google Scholar]
- Huang H., Zeqiraj E., Dong B., Jha B. K., Duffy N. M., Orlicky S., Thevakumaran N., Talukdar M., Pillon M. C., other authors (2014). Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity Mol Cell 53221–234 10.1016/j.molcel.2013.12.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kerr I. M., Brown R. E. (1978). pppA2’p5’A2’p5’A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells Proc Natl Acad Sci U S A 75256–260 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kristiansen H., Gad H. H., Eskildsen-Larsen S., Despres P., Hartmann R. (2011). The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities J Interferon Cytokine Res 3141–47 10.1089/jir.2010.0107. [DOI] [PubMed] [Google Scholar]
- Luytjes W., Bredenbeek P. J., Noten A. F., Horzinek M. C., Spaan W. J. (1988). Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus Virology 166415–422 10.1016/0042-6822(88)90512-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogden K. M., Hu L., Jha B. K., Sankaran B., Weiss S. R., Silverman R. H., Patton J. T., Prasad B. V. (2015). Structural basis for 2′-5′-oligoadenylate binding and enzyme activity of a viral RNase L antagonist J Virol 896633–6645 10.1128/JVI.00701-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otwinowski Z., Minor W. (1997). Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol 276307–326 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- Schindler C., Darnell J. E., Jr. (1995). Transcriptional responses to polypeptide ligands: the JAK-STAT pathway Annu Rev Biochem 64621–652 10.1146/annurev.bi.64.070195.003201. [DOI] [PubMed] [Google Scholar]
- Silverman R. H. (2007). Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response J Virol 8112720–12729 10.1128/JVI.01471-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silverman R. H., Weiss S. R. (2014). Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A J Interferon Cytokine Res 34455–463 10.1089/jir.2014.0007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D. (1998). How cells respond to interferons Annu Rev Biochem 67227–264 10.1146/annurev.biochem.67.1.227. [DOI] [PubMed] [Google Scholar]
- Thakur C. S., Xu Z., Wang Z., Novince Z., Silverman R. H. (2005). A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2′,5′ oligoadenylates Methods Mol Med 116103–113. [DOI] [PubMed] [Google Scholar]
- Wang Q., Carmichael G. G. (2004). Effects of length and location on the cellular response to double-stranded RNA Microbiol Mol Biol Rev 68432–452 10.1128/MMBR.68.3.432-452.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zaki A. M., van Boheemen S., Bestebroer T. M., Osterhaus A. D., Fouchier R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia N Engl J Med 3671814–1820 10.1056/NEJMoa1211721. [DOI] [PubMed] [Google Scholar]
- Zhang R., Jha B. K., Ogden K. M., Dong B., Zhao L., Elliott R., Patton J. T., Silverman R. H., Weiss S. R. (2013). Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity Proc Natl Acad Sci U S A 11013114–13119 10.1073/pnas.1306917110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao L., Rose K. M., Elliott R., Van Rooijen N., Weiss S. R. (2011). Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus J Virol 8510058–10068 10.1128/JVI.05075-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao L., Jha B. K., Wu A., Elliott R., Ziebuhr J., Gorbalenya A. E., Silverman R. H., Weiss S. R. (2012). Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology Cell Host Microbe 11607–616 10.1016/j.chom.2012.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.